Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS)
CTNS
1 other identifier
interventional
1,020
1 country
1
Brief Summary
The Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS) is a 13-year study designed primarily to evaluate the safety and efficacy of a vitamin-mineral supplement (Centrum) containing recommended daily-allowance dosage (RDA) in preventing age-related cataract or delaying its progression in participants with early or no cataract at baseline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started May 1995
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 1995
CompletedFirst Submitted
Initial submission to the registry
March 29, 2006
CompletedFirst Posted
Study publicly available on registry
March 31, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2007
CompletedResults Posted
Study results publicly available
April 24, 2012
CompletedMay 6, 2013
April 1, 2013
12 years
March 29, 2006
March 28, 2012
April 30, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Showing Development or Progression of Age-related Cataract or Undergoing Cataract Surgery During Follow-up
number of participants in whom any of the following occur in at least one eligible eye during follow-up: cataract surgery; nuclear opacity: a 1.5 U increase in opalescence from baseline; cortical opacity: a 10% increase in area within a standard 5 mm circle area of the lens from baseline; posterior subcapsular opacity: a 5% increase in area within a standard 5 mm circle area of the lens from baseline.
at yearly intervals from baseline for approximately ten years
Secondary Outcomes (5)
Number of Participants Showing Development or Progression of Nuclear Lens Opacities
at yearly intervals from baseline for approximately ten years
Number of Participants Showing Development or Progression of Cortical Lens Opacities
at yearly intervals from baseline for approximately ten years
Number of Participants Showing Development or Progression of Posterior Subcapsular Opacities
at yearly intervals from baseline for approximately ten years
Number of Participants Undergoing Cataract Surgery
at 6 month intervals from baseline for approximately 10 yrs
Number of Participants With a Decrease in Visual Acuity
at 6 month intervals from baseline for approximately 10 yrs
Study Arms (2)
Centrum
EXPERIMENTALmultivitamin-mineral supplement. RDA dosage. 1 tablet a day for the whole study duration.
placebo
PLACEBO COMPARATORplacebo pills. One tablet a day for the whole study duration.
Interventions
Eligibility Criteria
You may qualify if:
- Clinical and photographic diagnosis of early or no age-related cataract
- Participants with early cataract must have at least one eligible eye with VA score 20/32 or better
- Participants with no cataract must have VA score 20/32 or better in both eyes.
You may not qualify if:
- Advanced cataract
- Bilateral aphakia or pseudophakia
- Any ocular disease or condition that might complicate the future evaluation of cataract
- Regular use of nutritional supplements
- Failure to take at least 75% of run-in medication
- Cancer with evidence of recurrence in the past 5 years
- Major cerebral or cardiovascular events in past 12 months
- Current participation to other clinical trials
- Any condition likely to prevent adherence to CTNS follow-up schedule
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dpt. Scienze Otorino-Odonto Oftalmologiche, University of Parma
Parma, 43100, Italy
Related Publications (4)
CTNS Study Group. The Italian-American Clinical Trial of Nutritional Supplements and Age-Related Cataract (CTNS): design implications. CTNS report no. 1. Control Clin Trials. 2003 Dec;24(6):815-29. doi: 10.1016/s0197-2456(03)00095-3.
PMID: 14662284BACKGROUNDFerrigno L, Aldigeri R, Rosmini F, Sperduto RD, Maraini G; Italian-American Cataract Study Group. Associations between plasma levels of vitamins and cataract in the Italian-American Clinical Trial of Nutritional Supplements and Age-Related Cataract (CTNS): CTNS Report #2. Ophthalmic Epidemiol. 2005 Apr;12(2):71-80. doi: 10.1080/09286580590932815.
PMID: 16019690RESULTClinical Trial of Nutritional Supplements and Age-Related Cataract Study Group; Maraini G, Williams SL, Sperduto RD, Ferris F, Milton RC, Clemons TE, Rosmini F, Ferrigno L. A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3. Ophthalmology. 2008 Apr;115(4):599-607.e1. doi: 10.1016/j.ophtha.2008.01.005.
PMID: 18387406RESULTMaraini G, Williams SL, Sperduto RD, Ferris FL, Milton RC, Clemons TE, Rosmini F, Ferrigno L. Effects of multivitamin/mineral supplementation on plasma levels of nutrients. Report No. 4 of the Italian-American clinical trial of nutritional supplements and age-related cataract. Ann Ist Super Sanita. 2009;45(2):119-27.
PMID: 19636163RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Giovanni Maraini, MD
- Organization
- University of Parma
Study Officials
- STUDY CHAIR
Giovanni Maraini, MD
University of Parma
- PRINCIPAL INVESTIGATOR
Robert D Sperduto, MD
National Eye Institute (NEI)
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2006
First Posted
March 31, 2006
Study Start
May 1, 1995
Primary Completion
May 1, 2007
Study Completion
May 1, 2007
Last Updated
May 6, 2013
Results First Posted
April 24, 2012
Record last verified: 2013-04